Search research articles
Contact Us
Filters
Showing results (451-460 of 507) with videos related to
Page
of 51
Sort By:
Immunotherapy Advances
|
August 3, 2022
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
D Tatovic, M A McAteer, J Barry, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Journal of the American Academy of Dermatology
|
June 21, 2020
International collaboration and rapid harmonization across dermatologic COVID-19 registries
Esther E Freeman, Devon E McMahon, George J Hruza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Cell Reports
|
October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
ESMO Open
|
June 25, 2025
Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma
R S Traweek, M Zoghbi, R Lazcano, et al.
The British Journal of Dermatology
|
September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)
T H Sach, K S Thomas, J M Batchelor, et al.
Nature Communications
|
June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Health Technology Assessment (Winchester, England)
|
November 27, 2020
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT
Jonathan M Batchelor, Kim S Thomas, Perways Akram, et al.
Page
of 51
Search research articles
Search
Showing results (451-460 of 507) with videos related to
Sort By:
Page
of 51
Immunotherapy Advances
|
August 3, 2022
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
D Tatovic, M A McAteer, J Barry, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Journal of the American Academy of Dermatology
|
June 21, 2020
International collaboration and rapid harmonization across dermatologic COVID-19 registries
Esther E Freeman, Devon E McMahon, George J Hruza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Cell Reports
|
October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
ESMO Open
|
June 25, 2025
Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma
R S Traweek, M Zoghbi, R Lazcano, et al.
The British Journal of Dermatology
|
September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)
T H Sach, K S Thomas, J M Batchelor, et al.
Nature Communications
|
June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Health Technology Assessment (Winchester, England)
|
November 27, 2020
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT
Jonathan M Batchelor, Kim S Thomas, Perways Akram, et al.
Page
of 51